News from Bayer HealthCare Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 20, 2015, 02:35 ET Bayer Submits New Drug Application for LCS-16 for Pregnancy Prevention for up to Five Years

Bayer HealthCare Pharmaceuticals announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration...


Oct 28, 2013, 09:51 ET Bayer to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets

 Bayer HealthCare today announced preliminary results from two ongoing, open-label, long-term extension studies investigating its recently...


Oct 08, 2013, 18:54 ET FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...


Sep 25, 2013, 08:30 ET Bayer's Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

WHIPPANY, N.J., Sept. 25, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA)...


Aug 06, 2013, 15:18 ET FDA Advisory Committee Unanimously Recommends Approval Of Bayer's Riociguat In Two Pulmonary Hypertension Indications

 Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee...


Jul 28, 2011, 13:13 ET New Jersey Governor's School in the Sciences to Tackle Human Memory

Bayer HealthCare Pharmaceuticals is pleased to sponsor a newly expanded curriculum developed and facilitated by Drew science faculty at this...


Apr 28, 2011, 12:40 ET Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million

Bayer HealthCare Pharmaceuticals and the World Federation of Hemophilia (WFH) are announcing a three-year extension of Bayer's sponsorship...


Mar 15, 2011, 06:00 ET U.S. FDA Approves Bayer's Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System

Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol)...


Mar 14, 2011, 22:51 ET U.S. FDA Approves Bayer's Gadavist™ (Gadobutrol) Injection for MRI of the Central Nervous System

Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist™ (gadobutrol)...


Jan 21, 2011, 13:13 ET FDA Advisory Committee Recommends Approval of Bayer's Gadobutrol Injection for MRI of the Central Nervous System

Bayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and...


Jan 08, 2011, 14:45 ET Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Group's Alcohol Prep Products

- Bayer HealthCare Pharmaceuticals has become aware of a broad United States market recall of alcohol prep pads, swabs and swabsticks manufactured...


Jul 22, 2010, 14:49 ET Bayer HealthCare Pharmaceuticals Supports New Jersey Governor's School in the Sciences at Drew University

Bayer HealthCare Pharmaceuticals is pleased to announce it will support the New Jersey Governor's School in the Sciences (NJGSS) at Drew...


Jul 09, 2010, 09:30 ET Data on Bayer HealthCare's Florbetaben PET Tracer to Be Presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010

Bayer HealthCare Pharmaceuticals, Inc. today announced that data on the company's investigational PET amyloid imaging tracer Florbetaben (BAY...


Jun 17, 2010, 17:10 ET Teva Admits to Making False Statements in US Gianvi™ Label and Agrees to Corrective Measures

In a June 16, 2010 proceeding before Judge Virginia Kendall in US Federal Court in the Northern District of Illinois, Teva Pharmaceuticals USA Inc....


Jun 03, 2010, 08:00 ET Bayer HealthCare Launches First iPhone Application with Personalized Tools to Assist People on Betaseron® (interferon beta-1b) in Managing Their Multiple Sclerosis Treatment

Bayer HealthCare Pharmaceuticals today launched a new tool using a technology that many people with multiple sclerosis (MS) already have in their...


May 06, 2010, 09:06 ET Women's Empowerment Icons Commemorate the 50th Anniversary of the Pill

In celebration of the 50th anniversary of the Pill, Bayer HealthCare Pharmaceuticals is collaborating with some of the most influential female...


Mar 11, 2010, 09:00 ET FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis

Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA)...


Oct 30, 2009, 09:30 ET Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology

Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral...


Oct 01, 2009, 17:58 ET FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users

Bayer HealthCare Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for...


Feb 18, 2008, 00:00 ET Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer

WAYNE, N.J. and EMERYVILLE, Calif., Feb. 18 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today...


Dec 18, 2007, 00:00 ET Bayer HealthCare Awards Grant to Multiple Sclerosis Foundation

WAYNE, N.J., Dec. 18 /PRNewswire/ -- Bayer HealthCare today announced a charitable gift of $85,000 to the Multiple Sclerosis Foundation (MSF) to...


Nov 07, 2007, 00:00 ET BRIGHT Results Show Less Pain and Higher Patient Satisfaction with Betaseron(R) than with Rebif(R)

WAYNE, N.J., Nov. 7 /PRNewswire/ -- Patients with relapsing-remitting multiple sclerosis (MS) treated with 250 mcg Betaseron (interferon...


Aug 02, 2007, 01:00 ET Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

WAYNE, N.J., Aug. 2 /PRNewswire/ -- Patients treated with Betaseron(R) (interferon beta-1b) shortly after their first clinical MS event or...


May 03, 2007, 01:00 ET Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron(R)

BOSTON, May 3 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today the results of three clinical studies with Betaseron(R)...


May 01, 2007, 01:00 ET First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron(R) Significantly Delayed Permanent Disability

BOSTON, May 1 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today new data, which show that immediate initiation(1) of Betaseron(R)...